Answers are grounded in this paper and cite their sources.
Observational study reveals altered B vitamin-related metabolite patterns in older adults with metabolic syndrome, highlighting potential biomarker pathways for disease management.
Metabolic syndrome (MetS) is a major global health challenge associated with increased risks of cardiovascular disease, type 2 diabetes, and mortality, particularly among older adults. B vitamins are essential cofactors in the homocysteine–methionine, folate, and tryptophan–kynurenine pathways, which regulate inflammation, oxidative stress, and glucose metabolism. This study investigated associations between B vitamin–related metabolites and MetS in 400 adults aged ≥ 60 years from the Bushehr Elderly Health (BEH) program. Demographic, lifestyle, and clinical data were collected, and fasting blood samples were analyzed using GC-MS/MS and LC-MS/MS. MetS was defined according to International Diabetes Federation criteria. Principal component analysis (PCA) identified metabolite patterns, and logistic regression assessed their associations with MetS. MetS was present in 45.8% of participants. Individuals with MetS had higher levels of total cysteine and several folate-related metabolites, nicotinamide and kynurenine pathway metabolites, whereas serine levels were lower. Factor 1, identified by PCA and consisting of kynurenine, quinolinic acid, kynurenic acid, 3-hydroxykynurenine, cystathionine, anthranilic acid, neopterin, and total cysteine, was associated with 36% higher odds of MetS after adjustment for covariates. These findings indicate significant alterations in B vitamin–related metabolic pathways and suggest potential biomarkers and therapeutic targets for MetS management.
No takes yet. Share an insight, caveat, or question.
Soltani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: